David Sans - Chief of Corporate Development at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief of Corporate Development
Stock Symbol
CLDI, CLDI-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Sans since 9/18/2023

Holdings reported by David Sans for Calidi Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18.3K $33K $1.80 Sep 12, 2023 Direct

There are no transactions reported by David Sans for Calidi Biotherapeutics, Inc.